Zum Inhalt springen
Shenzhen Oriental PharmaceuticalShenzhen Oriental PharmaceuticalOrientalSpezial-APIs seit 1995
← Regulatorische Ressourcen
EU 4 min

Written Confirmation for API imports into the EU

Since 2013, APIs imported into the EU from third countries need a Written Confirmation from the exporting authority — unless the country is on the equivalence list. Here is what exporters must know.

The Falsified Medicines Directive requirement

Under Directive 2011/62/EU (Falsified Medicines Directive, FMD), since 2 July 2013 every batch of an active substance imported into the EU for medicinal use must be accompanied by a Written Confirmation (WC) issued by the competent authority of the exporting third country.

What the Written Confirmation states

The WC confirms that, for the specific API and manufacturing site:

  • GMP standards at least equivalent to the EU's apply;
  • the site is subject to regular GMP inspections;
  • in case of findings, the authority will inform the EU.

Equivalence (white-list) countries

The EU maintains a list of third countries recognised as having equivalent regulatory frameworks (e.g. Switzerland, Japan, USA, and others). APIs from these countries are exempt from the WC requirement. China is not on the equivalence list, so a Written Confirmation is required.

What this means for Chinese API exports

For an API shipped from China into the EU, the exporter must obtain the WC from the Chinese competent authority (NMPA) for each shipment/site. As an experienced exporter to the EU, we handle the WC process for our EU-bound products and support customers with the required documentation.

Requirements and country lists change. Always confirm the current FMD/WC status with the importing EU authority.
Allgemeine Informationen; keine rechtliche oder regulatorische Beratung. Anforderungen ändern sich — bitte stets mit der zuständigen Behörde bestätigen lassen.

Benötigen Sie ein Dossier für einen bestimmten Markt?

Nennen Sie uns Zielland und Produkt — wir beraten Sie zum Dossier, das wir bereitstellen können.

Fragen an unser Team

Ähnliche Produkte

Phenylephrine Hydrochloride

Flaggschiff
Cardiovascular & Vasopressors
CAS61-76-7
StandardUSP/EP/CP
Regulatorische UnterlagenEU WC GD250011 · US-DMF on request
· SDS auf Anfrage verfügbar

Phenylephrine Bitartrate

Flaggschiff
Cardiovascular & Vasopressors
CAS17162-39-9
StandardUSP
Regulatorische UnterlagenAuf Anfrage verfügbar
· SDS auf Anfrage verfügbar

Phenylephrine base

Cardiovascular & Vasopressors
CAS59-42-7
StandardIHS/EP
Regulatorische UnterlagenAuf Anfrage verfügbar
· SDS auf Anfrage verfügbar